 | • レポートコード：MRC2-11QY12159 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血友病A・B治療材料のグローバル市場について調査・分析したレポートです。種類別（デスモプレシン、オクトコガルファ、ノナコガルファ、その他）市場規模、用途別（歯科医院、病院、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血友病A・B治療材料の競争状況、市場シェア ・世界の血友病A・B治療材料市場：種類別市場規模 2015年-2020年（デスモプレシン、オクトコガルファ、ノナコガルファ、その他） ・世界の血友病A・B治療材料市場：種類別市場規模予測 2021年-2026年（デスモプレシン、オクトコガルファ、ノナコガルファ、その他） ・世界の血友病A・B治療材料市場：用途別市場規模 2015年-2020年（歯科医院、病院、外来手術センター） ・世界の血友病A・B治療材料市場：用途別市場規模予測 2021年-2026年（歯科医院、病院、外来手術センター） ・北米の血友病A・B治療材料市場分析：米国、カナダ ・ヨーロッパの血友病A・B治療材料市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血友病A・B治療材料市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血友病A・B治療材料市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血友病A・B治療材料市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Arsia therapeutics、Spark Therapeutics, Inc.、Alnylam Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hemophilia is a rare, inherited disorder in which blood doesn’t clot normally due to the lack of sufficient blood clotting factor. Clotting factor is a protein required for blood clotting to occur normally.
Novel treatments for people suffering from hemophilia and other different bleeding problems has evolved over the past. Hemostasis requires a specific missing plasma protein to prevent unnecessary bleeding, they are named as different factors in the blood. Furthermore, these proteins are contained in concentrate products of lyophilized factor. The analysis in the report describes the purity and viral safety issues for most of the coagulation products currently available along with the market potential. A prompt treatment is required for therapeutic management of bleeding disorders during the bleeding episodes to minimize complications ascending from accumulation of blood in joint spaces that may result in compartment syndrome and have its own complication in health of an individual. There are number of treatment regimens available in the form of non-complicated and complicated bleeding episodes.
Market Analysis and Insights: Global Hemophillia A and B Therapeutics Materials Market
The global Hemophillia A and B Therapeutics Materials market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hemophillia A and B Therapeutics Materials Scope and Market Size
Hemophillia A and B Therapeutics Materials market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hemophillia A and B Therapeutics Materials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Arsia therapeutics
Spark Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc.
Sangamo Therapeutics, Inc.
…
Market segment by Type, the product can be split into
Desmopressin
Octocogalfa
Nonacogalfa
Others
Market segment by Application, split into
Dental Clinics
Hospitals
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemophillia A and B Therapeutics Materials Revenue
1.4 Market by Type
1.4.1 Global Hemophillia A and B Therapeutics Materials Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Desmopressin
1.4.3 Octocogalfa
1.4.4 Nonacogalfa
1.4.5 Others
1.5 Market by Application
1.5.1 Global Hemophillia A and B Therapeutics Materials Market Share by Application: 2020 VS 2026
1.5.2 Dental Clinics
1.5.3 Hospitals
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hemophillia A and B Therapeutics Materials Market Perspective (2015-2026)
2.2 Global Hemophillia A and B Therapeutics Materials Growth Trends by Regions
2.2.1 Hemophillia A and B Therapeutics Materials Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hemophillia A and B Therapeutics Materials Historic Market Share by Regions (2015-2020)
2.2.3 Hemophillia A and B Therapeutics Materials Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hemophillia A and B Therapeutics Materials Market Growth Strategy
2.3.6 Primary Interviews with Key Hemophillia A and B Therapeutics Materials Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hemophillia A and B Therapeutics Materials Players by Market Size
3.1.1 Global Top Hemophillia A and B Therapeutics Materials Players by Revenue (2015-2020)
3.1.2 Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Players (2015-2020)
3.1.3 Global Hemophillia A and B Therapeutics Materials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hemophillia A and B Therapeutics Materials Market Concentration Ratio
3.2.1 Global Hemophillia A and B Therapeutics Materials Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hemophillia A and B Therapeutics Materials Revenue in 2019
3.3 Hemophillia A and B Therapeutics Materials Key Players Head office and Area Served
3.4 Key Players Hemophillia A and B Therapeutics Materials Product Solution and Service
3.5 Date of Enter into Hemophillia A and B Therapeutics Materials Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hemophillia A and B Therapeutics Materials Historic Market Size by Type (2015-2020)
4.2 Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020)
5.2 Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hemophillia A and B Therapeutics Materials Market Size (2015-2020)
6.2 Hemophillia A and B Therapeutics Materials Key Players in North America (2019-2020)
6.3 North America Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020)
6.4 North America Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hemophillia A and B Therapeutics Materials Market Size (2015-2020)
7.2 Hemophillia A and B Therapeutics Materials Key Players in Europe (2019-2020)
7.3 Europe Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020)
7.4 Europe Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020)
8 China
8.1 China Hemophillia A and B Therapeutics Materials Market Size (2015-2020)
8.2 Hemophillia A and B Therapeutics Materials Key Players in China (2019-2020)
8.3 China Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020)
8.4 China Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hemophillia A and B Therapeutics Materials Market Size (2015-2020)
9.2 Hemophillia A and B Therapeutics Materials Key Players in Japan (2019-2020)
9.3 Japan Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020)
9.4 Japan Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hemophillia A and B Therapeutics Materials Market Size (2015-2020)
10.2 Hemophillia A and B Therapeutics Materials Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020)
10.4 Southeast Asia Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020)
11 India
11.1 India Hemophillia A and B Therapeutics Materials Market Size (2015-2020)
11.2 Hemophillia A and B Therapeutics Materials Key Players in India (2019-2020)
11.3 India Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020)
11.4 India Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hemophillia A and B Therapeutics Materials Market Size (2015-2020)
12.2 Hemophillia A and B Therapeutics Materials Key Players in Central & South America (2019-2020)
12.3 Central & South America Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020)
12.4 Central & South America Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Arsia therapeutics
13.1.1 Arsia therapeutics Company Details
13.1.2 Arsia therapeutics Business Overview
13.1.3 Arsia therapeutics Hemophillia A and B Therapeutics Materials Introduction
13.1.4 Arsia therapeutics Revenue in Hemophillia A and B Therapeutics Materials Business (2015-2020))
13.1.5 Arsia therapeutics Recent Development
13.2 Spark Therapeutics, Inc.
13.2.1 Spark Therapeutics, Inc. Company Details
13.2.2 Spark Therapeutics, Inc. Business Overview
13.2.3 Spark Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Introduction
13.2.4 Spark Therapeutics, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2015-2020)
13.2.5 Spark Therapeutics, Inc. Recent Development
13.3 Alnylam Pharmaceuticals, Inc.
13.3.1 Alnylam Pharmaceuticals, Inc. Company Details
13.3.2 Alnylam Pharmaceuticals, Inc. Business Overview
13.3.3 Alnylam Pharmaceuticals, Inc. Hemophillia A and B Therapeutics Materials Introduction
13.3.4 Alnylam Pharmaceuticals, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2015-2020)
13.3.5 Alnylam Pharmaceuticals, Inc. Recent Development
13.4 Sangamo Therapeutics, Inc.
13.4.1 Sangamo Therapeutics, Inc. Company Details
13.4.2 Sangamo Therapeutics, Inc. Business Overview
13.4.3 Sangamo Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Introduction
13.4.4 Sangamo Therapeutics, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2015-2020)
13.4.5 Sangamo Therapeutics, Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hemophillia A and B Therapeutics Materials Key Market Segments
Table 2. Key Players Covered: Ranking by Hemophillia A and B Therapeutics Materials Revenue
Table 3. Ranking of Global Top Hemophillia A and B Therapeutics Materials Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hemophillia A and B Therapeutics Materials Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Desmopressin
Table 6. Key Players of Octocogalfa
Table 7. Key Players of Nonacogalfa
Table 8. Key Players of Others
Table 9. Global Hemophillia A and B Therapeutics Materials Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Hemophillia A and B Therapeutics Materials Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Hemophillia A and B Therapeutics Materials Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Hemophillia A and B Therapeutics Materials Market Share by Regions (2015-2020)
Table 13. Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Hemophillia A and B Therapeutics Materials Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Hemophillia A and B Therapeutics Materials Market Growth Strategy
Table 19. Main Points Interviewed from Key Hemophillia A and B Therapeutics Materials Players
Table 20. Global Hemophillia A and B Therapeutics Materials Revenue by Players (2015-2020) (Million US$)
Table 21. Global Hemophillia A and B Therapeutics Materials Market Share by Players (2015-2020)
Table 22. Global Top Hemophillia A and B Therapeutics Materials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophillia A and B Therapeutics Materials as of 2019)
Table 23. Global Hemophillia A and B Therapeutics Materials by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Hemophillia A and B Therapeutics Materials Product Solution and Service
Table 26. Date of Enter into Hemophillia A and B Therapeutics Materials Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020) (Million US$)
Table 29. Global Hemophillia A and B Therapeutics Materials Market Size Share by Type (2015-2020)
Table 30. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Type (2021-2026)
Table 31. Global Hemophillia A and B Therapeutics Materials Market Size Share by Application (2015-2020)
Table 32. Global Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020) (Million US$)
Table 33. Global Hemophillia A and B Therapeutics Materials Market Size Share by Application (2021-2026)
Table 34. North America Key Players Hemophillia A and B Therapeutics Materials Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Hemophillia A and B Therapeutics Materials Market Share (2019-2020)
Table 36. North America Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020) (Million US$)
Table 37. North America Hemophillia A and B Therapeutics Materials Market Share by Type (2015-2020)
Table 38. North America Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020) (Million US$)
Table 39. North America Hemophillia A and B Therapeutics Materials Market Share by Application (2015-2020)
Table 40. Europe Key Players Hemophillia A and B Therapeutics Materials Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Hemophillia A and B Therapeutics Materials Market Share (2019-2020)
Table 42. Europe Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Hemophillia A and B Therapeutics Materials Market Share by Type (2015-2020)
Table 44. Europe Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Hemophillia A and B Therapeutics Materials Market Share by Application (2015-2020)
Table 46. China Key Players Hemophillia A and B Therapeutics Materials Revenue (2019-2020) (Million US$)
Table 47. China Key Players Hemophillia A and B Therapeutics Materials Market Share (2019-2020)
Table 48. China Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020) (Million US$)
Table 49. China Hemophillia A and B Therapeutics Materials Market Share by Type (2015-2020)
Table 50. China Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020) (Million US$)
Table 51. China Hemophillia A and B Therapeutics Materials Market Share by Application (2015-2020)
Table 52. Japan Key Players Hemophillia A and B Therapeutics Materials Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Hemophillia A and B Therapeutics Materials Market Share (2019-2020)
Table 54. Japan Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Hemophillia A and B Therapeutics Materials Market Share by Type (2015-2020)
Table 56. Japan Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Hemophillia A and B Therapeutics Materials Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Hemophillia A and B Therapeutics Materials Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Hemophillia A and B Therapeutics Materials Market Share (2019-2020)
Table 60. Southeast Asia Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Hemophillia A and B Therapeutics Materials Market Share by Type (2015-2020)
Table 62. Southeast Asia Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Hemophillia A and B Therapeutics Materials Market Share by Application (2015-2020)
Table 64. India Key Players Hemophillia A and B Therapeutics Materials Revenue (2019-2020) (Million US$)
Table 65. India Key Players Hemophillia A and B Therapeutics Materials Market Share (2019-2020)
Table 66. India Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020) (Million US$)
Table 67. India Hemophillia A and B Therapeutics Materials Market Share by Type (2015-2020)
Table 68. India Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020) (Million US$)
Table 69. India Hemophillia A and B Therapeutics Materials Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Hemophillia A and B Therapeutics Materials Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Hemophillia A and B Therapeutics Materials Market Share (2019-2020)
Table 72. Central & South America Hemophillia A and B Therapeutics Materials Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Hemophillia A and B Therapeutics Materials Market Share by Type (2015-2020)
Table 74. Central & South America Hemophillia A and B Therapeutics Materials Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Hemophillia A and B Therapeutics Materials Market Share by Application (2015-2020)
Table 76. Arsia therapeutics Company Details
Table 77. Arsia therapeutics Business Overview
Table 78. Arsia therapeutics Product
Table 79. Arsia therapeutics Revenue in Hemophillia A and B Therapeutics Materials Business (2015-2020) (Million US$)
Table 80. Arsia therapeutics Recent Development
Table 81. Spark Therapeutics, Inc. Company Details
Table 82. Spark Therapeutics, Inc. Business Overview
Table 83. Spark Therapeutics, Inc. Product
Table 84. Spark Therapeutics, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2015-2020) (Million US$)
Table 85. Spark Therapeutics, Inc. Recent Development
Table 86. Alnylam Pharmaceuticals, Inc. Company Details
Table 87. Alnylam Pharmaceuticals, Inc. Business Overview
Table 88. Alnylam Pharmaceuticals, Inc. Product
Table 89. Alnylam Pharmaceuticals, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2015-2020) (Million US$)
Table 90. Alnylam Pharmaceuticals, Inc. Recent Development
Table 91. Sangamo Therapeutics, Inc. Company Details
Table 92. Sangamo Therapeutics, Inc. Business Overview
Table 93. Sangamo Therapeutics, Inc. Product
Table 94. Sangamo Therapeutics, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2015-2020) (Million US$)
Table 95. Sangamo Therapeutics, Inc. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemophillia A and B Therapeutics Materials Market Share by Type: 2020 VS 2026
Figure 2. Desmopressin Features
Figure 3. Octocogalfa Features
Figure 4. Nonacogalfa Features
Figure 5. Others Features
Figure 6. Global Hemophillia A and B Therapeutics Materials Market Share by Application: 2020 VS 2026
Figure 7. Dental Clinics Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Hemophillia A and B Therapeutics Materials Report Years Considered
Figure 11. Global Hemophillia A and B Therapeutics Materials Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Hemophillia A and B Therapeutics Materials Market Share by Regions: 2020 VS 2026
Figure 13. Global Hemophillia A and B Therapeutics Materials Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Hemophillia A and B Therapeutics Materials Market Share by Players in 2019
Figure 16. Global Top Hemophillia A and B Therapeutics Materials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophillia A and B Therapeutics Materials as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Hemophillia A and B Therapeutics Materials Revenue in 2019
Figure 18. North America Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
歯科用CAD/CAM材料・システムの世界市場（～2026年） In dentistry, CAD/CAM is used to manufacture dental restorations such as crowns, crown lays, veneers, inlays & onlays, fixed bridges, dental implant restorations, dentures, orthodontics, and even full-mouth reconstruction. The use of this in dentistry is on a continuous rise as it ensures sufficient…- 犬インフルエンザ治療薬の世界市場（～2026年） Canine flu, which is also called dog flu; is a contagious disease that affects the dog’s respiratory system. It is mainly caused by canine influenza virus/Type An influenza virus. There are two types of influenza viruses H3N2 virus H3N8 virus. Market Analysis and Insights: Global Canine Flu Therapeu…
- 淋病治療薬の世界市場（～2026年） Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep…
- 皮膚糸状菌性爪真菌症治療薬（DOT）の世界市場（～2026年） Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs.…
- 肥大型心筋症治療薬の世界市場（～2026年） HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ, and cardiomyopathy refers …